Sponsor or institution
Clinical trials and research at Lakefront Biotherapeutics West LLC
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Lakefront Biotherapeutics West LLC that are recruiting, at sites in 3 countries (most in Australia (1), United States (1), New Zealand (1)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
OM336 in seropositive autoimmune diseases
A first-in-human study testing OM336 to see if it is safe and tolerable in adults with seropositive autoimmune diseases, given as subcutaneous injections in increasing doses.
-
OM336 for autoimmune hemolytic anemia and immune thrombocytopenia
This phase 1 trial will test whether subcutaneously given OM336 is safe and tolerable in adults with relapsed or refractory autoimmune hemolytic anemia or immune thrombocytopenia.
Quick answers
How many clinical trials run by Lakefront Biotherapeutics West LLC are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Australia (1 trial), United States (1 trial), New Zealand (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.